Autologous Costal Osteochondral Transplantation for Talar Osteochondral Lesions
NCT ID: NCT05942430
Last Updated: 2023-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2023-09-01
2028-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Whether autologous costal osteochondral transplantation can achieve better clinical outcomes and cartilage repair quality with lower donor site morbidity than autologous osteoperiosteal transplantation in the treatment of Hepple Stage V talar osteochondral lesions.
Participants will be randomly assigned to the intervention group (undergoing autologous costal osteochondral transplantation) or the control group (undergoing autologous osteoperiosteal transplantation). Both groups of participants will receive the same postoperative rehabilitation process and follow-up evaluation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Autologous Osteoperiosteal Transplantation for the Treatment of Severe Osteochondral Lesions of the Talus
NCT06527482
Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect
NCT02291926
Stem Cell Transplantation for the Treatment of Knee Osteoarthritis
NCT00550524
Comparison of Autologous Chondrocyte Implantation Versus Mosaicoplasty: a Randomized Trial
NCT00560664
Subchondroplasty® Knee RCT
NCT03112200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The costa group
Autologous costal osteochondral transplantation
Autologous costal osteochondral transplantation
Operating steps:
1. Arthroscopic examination of the size and location of the talar osteochondral lesion;
2. Make a transverse incision (approximately 4 cm long) at the osteochondral junction of the fifth or sixth rib, and harvest an osteochondral column from the rib;
3. Thoroughly remove the talar osteochonral lesion through arthrotomy or Chevron osteotomy of the medial malleolus;
4. Trim the autograft according to the size of the lesion;
5. Fill the peri-lesion cavity with cancellous bone, and finally embed the costal osteochondral autograft into the talar defect, ensuring that the cartilage surface of the transplant to be flush with the normal talar cartilage around it;
6. Suture the joint capsule or reduct and fix the medial malleolus, and close the incision layer by layer.
The ilium group
Autologous iliac osteoperiosteal transplantation
Autologous iliac osteoperiosteal transplantation
Operating steps:
1. Arthroscopic examination of the size and location of the talar osteochondral lesion;
2. Make an incision along the anterior iliac crest. At the time of exposure, pay attention not to damage the periosteum. Obtain a cylindrical osteoperiosteal column by an appropriate-sized harvester tube.
3. Thoroughly remove the talar osteochonral lesion through arthrotomy or Chevron osteotomy of the medial malleolus;
4. Fill the peri-lesion cavity with cancellous bone, and finally embed the iliac osteoperiosteal autograft into the talar defect, ensuring that the periosteum surface of the transplant to be flush with the normal talar cartilage around it;
5. Suture the joint capsule or reduct and fix the medial malleolus, and close the incision layer by layer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autologous costal osteochondral transplantation
Operating steps:
1. Arthroscopic examination of the size and location of the talar osteochondral lesion;
2. Make a transverse incision (approximately 4 cm long) at the osteochondral junction of the fifth or sixth rib, and harvest an osteochondral column from the rib;
3. Thoroughly remove the talar osteochonral lesion through arthrotomy or Chevron osteotomy of the medial malleolus;
4. Trim the autograft according to the size of the lesion;
5. Fill the peri-lesion cavity with cancellous bone, and finally embed the costal osteochondral autograft into the talar defect, ensuring that the cartilage surface of the transplant to be flush with the normal talar cartilage around it;
6. Suture the joint capsule or reduct and fix the medial malleolus, and close the incision layer by layer.
Autologous iliac osteoperiosteal transplantation
Operating steps:
1. Arthroscopic examination of the size and location of the talar osteochondral lesion;
2. Make an incision along the anterior iliac crest. At the time of exposure, pay attention not to damage the periosteum. Obtain a cylindrical osteoperiosteal column by an appropriate-sized harvester tube.
3. Thoroughly remove the talar osteochonral lesion through arthrotomy or Chevron osteotomy of the medial malleolus;
4. Fill the peri-lesion cavity with cancellous bone, and finally embed the iliac osteoperiosteal autograft into the talar defect, ensuring that the periosteum surface of the transplant to be flush with the normal talar cartilage around it;
5. Suture the joint capsule or reduct and fix the medial malleolus, and close the incision layer by layer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Failed conservative treatment for at least 6 months;
* Unilateral talar osteochondral lesions without corresponding lesions on the tibial side;
* Willingness to participate in this clinical trial and signing an informed consent form.
Exclusion Criteria
* Combined with hip or knee joint diseases.
* Combined with ipsilateral ankle arthritis with joint space narrowing .
* Diagnosis of gouty arthritis of the ankle joint.
* Combined with osteoporosis (T score \<-2.5).
* Other conditions considered inappropriate for participation in this clinical trial by the researchers.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Third Affiliated Hospital of Southern Medical University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Canjun Zeng
Director of the Department of Foot and Ankle Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Canjun Zeng, PhD
Role: PRINCIPAL_INVESTIGATOR
The Third Affiliated Hospital of Southern Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Third Affiliated Hospital of Southern Medical University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Junyan Li
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YL202203
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2023-Lunshen-017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.